Studies on the pyrolysis of the synthetic cannabinoid agonist UR-144 ((1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) have shown that its major pyrolysis product is a tetramethylcyclopropane ring-opened alkene. Considering that smoking is a common way of ingesting synthetic cannabimimetics, the presence of the metabolites of this pyrolysis product would be expected in biological fluids. Using GC-MS and LC-MS-MS methods, a series of phase I metabolites of UR-144 and its pyrolysis product were detected in the urine samples from patients admitted to hospital with suspected drug intoxication. The metabolites were tentatively identified as the products of mono-hydroxylation, di-hydroxylation, mono-hydroxylation with formation of the carbonyl group on the N-alkyl chain, carboxylation and N-dealkylation with mono-hydroxylation. In the case of the UR-144 pyrolysis product, metabolites with hydration of the aliphatic double bond were also identified. The parent compounds were detected as trace amounts in some urine samples, and the hydrated derivative of the UR-144 pyrolysis product was detected in the majority of samples. The detection of mono-hydroxylated metabolites of UR-144 (LC -MS-MS) and mono-hydroxylated/with hydration metabolites of the UR-144 pyrolysis product (GC-MS) was found to be the most useful method of establishing UR-144 ingestion.
Introduction
Synthetic alkylindoles have been reported to be cannabinoid receptor (CB1 and CB2) agonists, and are widely used as recreational drugs for their marijuana-like psychophysiologic effects (1) . Over the past several years, numerous synthetic alkylindole cannabimimetics have been identified in smoking mixtures sold as "legal highs," and this has prompted a number of countries to introduce legislative controls (1, 2) . One such compound, UR-144 ((1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone), was originally synthesized by Abbot Laboratories (3), and its detection in 'legal highs' has recently been reported (4, 5) . It is controlled in New Zealand and Russia (6) .
Synthetic alkylindole cannabimimetics have been detected in blood (7) (8) (9) (10) (11) (12) , oral fluid (13, 14) , hair (15, 16) and other tissues (17) as parent compounds. However, alkylindole cannabimimetics undergo extensive metabolism and the parent compounds are normally absent, or present at low levels, in urine (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . Mono-and poly-hydroxylations of parent compounds with subsequent conjugation have been reported to be major metabolic pathways. Recently, an investigation into the in vitro and in vivo metabolism of UR-144 has been reported (37) . Mono-hydroxylated metabolites with the hydroxyl group on the tetramethylcyclopropane ring and the N-pentyl chain were identified by in vitro metabolism studies and also in human urine samples.
Considering that UR-144 is normally ingested by smoking, it is necessary to consider the contribution of thermal degradation products to the metabolic profile (38) (39) (40) (41) . In recent work, the major pyrolysis product was identified as an isomer of UR-144 formed by an asymmetrical opening of a tetramethylcyclopropane ring (42) . This compound can be easily and reversibly hydrated. In this work, the detection of the metabolites of UR-144 and its pyrolysis product in human urine by GC-MS and LC-MS-MS methods is reported.
Experimental

Chemicals
High performance liquid chromatography (HPLC) gradientgrade acetonitrile was obtained from Panreac Quimica S.A. (Barcelona, Spain). N, O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA) containing 1% trimethylchlorosilane was purchased from Acros Organics (Geel, Belgium). Ammonium formate (analytical grade) and b-glucuronidase (type HP-2) were obtained from Sigma-Aldrich (Steincheim, Germany). The other solvents and chemicals (analytical grade) were supplied by Ecos-1 (Moscow, Russia).
Urine samples
Urine samples were collected (January to August 2012) from patients who were admitted to hospital with suspected drug intoxication. During this period, UR-144 was reportedly one of the most widely used cannabimimetics in Russia. Forty-five samples were found to be UR-144 positive using a screening protocol (acid hydrolysis and GC-MS analysis without derivatization) (see Supplementary data). Twenty urine samples containing high concentrations of UR-144 metabolites were examined in this study. Metabolites of other cannabimimetics were detected in four of these samples: RCS-4 (one sample), APINACA (two samples) (43) and JWH-018 with JWH-210 (one sample). No other psychoactive drugs were detected by routine GC-MS screening. Collection of urine samples was performed in accordance with Russian law.
Almost half of the patients admitted using the herbal or 'resinous' smoking mixtures. Herbal smoking mixtures were confiscated from five patients and analyzed. These were found to contain UR-144.
Preparation of urine samples b-Glucuronidase (50 ml) and phosphate buffer (0.8 M, pH 5.5, 1 ml) were added to urine (2.5 ml) followed by incubation at 378C for 24 h. After cooling, carbonate buffer (3 M, pH 10, 1 ml) was added and the mixture was extracted with chloroform (2 Â 3 ml). The combined extracts were evaporated to dryness and dissolved in a mixture of mobile phases A and B (1:1 v/v, 100 ml) for LC-MS-MS) or derivatized (for GC-MS).
Additionally, an acid de-conjugation was used. Hydrochloric acid (0.25 ml, 30%) was added to urine (2.5 ml) and the mixture was heated at 90-958C for 60 min. After cooling, the pH was adjusted to 8-9 with aqueous ammonium hydroxide solution (25%). Derivatization trimethylsilylation (TMS) of samples was performed using a mixture of BSTFA and ethyl acetate (50 ml, 1:1 v/v) at 608C for 20 min.
GC-MS and LC-MS-MS
A 6890 GC, coupled to a 5975VL MSD (Agilent Technologies, Santa Clara, CA, USA), was used with an Agilent VF-5 ms column (30 m Â 0.25 mm Â 0.25 mm). The temperature program was as follows: 508C (0.5 min), 998C/min (1008C, 1 min) and 158C/min (2808C, 15 min). Helium (1 ml/min) was used as the carrier gas. The temperatures of injector and transfer line were set at 270 and 2908C, respectively. Samples (0.2 ml) were injected in a splitless mode. Mass spectra were acquired in the electron ionization (EI) mode (70 eV), with the temperatures for the ion source and quadrupole set at 230 and 1508C, respectively. The linear retention indices (RIs) were calculated using a set of hydrocarbons (even numbering from C 20 to C 36 ).
A 1200 series micro-flow LC system fitted with a Zorbax Eclipse XDB-C18 column (2.1 mm Â 150 mm, 3.5 mm; 408C), coupled to a 6460 triple-quadrupole MSD (Agilent Technologies), was used. Separations (5 ml injected) were performed in the gradient mode with the mobile phases A (ammonium formate buffer, pH 5, 20 mM) and B (acetonitrile) as follows: 40% of phase B (1 min); linear gradient to 90% of phase B (15 min), which was kept for 4 min. The mobile phase flow rate was 0.25 ml/min. MS condition were as follows: positive electrospray ionization (ESI) mode; drying gas (nitrogen), 3008C (7 l/min); capillary voltage, 3500 V; nozzle voltage, 500 V; fragmentor voltage, 80 V; collision energy, 20 V.
Another Agilent 1200 LC with DAD fitted with a Zorbax Eclipse XDB-C18 column (4.6 mm Â 150 mm, 5 mm; 408C) was used for the semi-preparative separations of urine samples. The chromatography conditions were the same as for LC-MS-MS, except for the mobile-phase flow rate (1 ml/min) and injected sample volume (100 ml). Fractions (1 ml) were collected from 1.1 min (a void volume of chromatographic system) to 19.1 min after injection (retention time of UR-144, 17.9 min).
Results and Discussion
Parent compounds and their transformations Pyrolysis of UR-144 has been reported to lead to the opening of a tetramethylcyclopropane ring with the formation of compound 2 ( Figure 1 ) (42) . Both UR-144 and compound 2 are readily hydrolyzed in acidic media and, in case of 2, the reaction was found to be reversible. Interconversions between compounds 3-5 (the structures of compounds 4 and 5 are presumed) were found to be pH and solvent dependent. Compound 4 was observed as a GC artifact. Mass spectra and fragmentation pathways for UR-144 and its pyrolysis product (2) are given in Figure 2 . The characteristic ions, m/z 144 and 214, corresponding to the indole acylium and N-pentylindole acylium moieties, respectively, are observed in all spectra. The presence of the unaltered tetramethylcyclopropane moiety is indicated by the ion m/z 125, in the ESI spectra. The radical cation, m/z 229, formed by the migration of a proton from the aliphatic (or hexyl) moiety, is typical in the EI mass spectra of UR-144 and related compounds (5, 37, 42) . Taking into account the existence of two initial compounds (i.e. UR-144 and 2), it would be expected that two groups of metabolites (denoted as M1.x and M2.x) would be observed in urine.
Compound 3 (its product ion spectrum is almost identical to that of compound 2) was detected in 10 of the 20 urine samples (Figure 3b ). UR-144 and compound 2 were found in trace amounts in eight samples.
Mono-hydroxylated and mono-hydroxylated (with hydration of the aliphatic double bond) metabolites The chromatograms and mass spectra of the mono-hydroxylated metabolites are given in Figures 3 -5 . Three mono-hydroxylated metabolites of UR-144 (M1.1 -M1.3) containing a hydroxyl group on different positions of the N-pentyl chain were identified by the presence of the ions m/z 144 and 125 in the ESI mass spectra (Figure 4a) . Additionally, the ion m/z 230 indicated hydroxylation of the N-pentylindole moiety. These compounds underwent thermal isomerization during GC analysis.
The metabolites M1.4 and M1.5 also underwent thermal isomerization during GC analysis, and their ESI spectra indicated the presence of an unchanged N-pentylindole moiety (Figure 4b ). These observations, together with the EI fragmentation patterns, suggest hydroxylation of the unopened tetramethylcyclopropane ring. The existence of two observable compounds can be explained by the formation of diastereomers (see Supplementary data for EI mass spectra).
The remaining mono-hydroxylated metabolites were tentatively identified as metabolic products of compound 2. Metabolite M2.1 was found to have a hydrated double bond and a hydroxyl group positioned on one of the methyl groups in the ring-opened tetramethylcyclopropane moiety (Figures 3b and  4c) . The ESI and EI (TMS derivative, Figure 5b ) fragmentation pathways of M2.1 were found to be similar. The ions m/z 214 and 229 (EI) and 230 (ESI) indicated an unchanged N-pentylindole moiety. Additionally, the ions m/z 171 (EI) and 99 (ESI) corresponded to dehydration (LC -MS-MS) or elimination of trimethylsilanol (GC-MS) from a mono-hydroxylated heptyl fragment. This facile elimination that occurred under MS conditions suggests a tertiary position of hydroxyl group. Metabolite M2.1 underwent a reversible reaction (M2.1 $ M2.1-H 2 O) that was found to occur on the LC column. This was partially suppressed by increasing the pH of the eluent. The ESI mass spectrum of M2.1-H 2 O was similar to that of M2.1, and its major EI fragmentation pathway (TMS derivatization) involved the elimination of the methyl group, which is similar to compound 4 (42). Metabolite M2.2 ( Figure 4d ) was found to be an N-alkyl chain hydroxylated product. It is possible that metabolites M2.1 and M2.2 were formed by the metabolic epoxidation of the aliphatic double bond. Hydrated metabolites cannot be used for quantitative analyses due to their instability.
The ESI fragmentation of M2.6 was similar to that of M2.1, suggesting a similar location of the hydroxyl group. The metabolites M2.3 -M2.5 (Figure 4e ) had the hydroxyl group situated on the N-pentyl chain. Metabolites M2.7 and M2.8 contained a hydroxylated indole ring. These compounds co-eluted under LC conditions, but were separable by GC.
Di-hydroxylated and di-hydroxylated (with hydration) metabolites Ten di-hydroxylated metabolites were detected in all examined urine samples (Figures 6 -8) . The hydroxyl groups in metabolites M1.10-M1.13 were located on the N-pentyl chain and on the tetramethylcyclopropane moiety as indicated by the presence of the ions m/z 144 (unchanged indole ring) and 230 (monohydroxylation of N-pentylindole moiety). The EI fragmentation and thermal instability of M1.10-M1.13 under GC conditions confirmed the proposed structures. Metabolite M1.14 contained the hydroxyl groups on the N-pentyl chain and the indole ring. The relative prevalence of M1.14 was found to be very low. Metabolic hydroxylation of the indole ring in other alkylindole cannabimimetics has previously been reported to be insignificant (20, 21, 23, 24, 26 -34, 36, 37) .
Two di-hydroxylated/with hydration metabolites of compound 2 (M2.10 and M2.11, Figures 7c and 8 ) were also observed with the second hydroxyl group located on the N-pentyl chain. Metabolites M2.12 and M2.13 (Figure 7d ) are believed to be dehydrated analogues of M2.10 and M2.11. The ions m/z 160 and 246 in the ESI mass spectrum of metabolite M2.14 indicated that the hydroxyls were located on the indole ring and N-pentyl chain.
Mono-hydroxylated metabolites with a carbonyl group and their hydrated products Three UR-144 metabolites (M1.20-M1.22) containing a carbonyl group on the N-pentyl chain were detected (Figures 9 and  10 ) with the ion m/z 85, indicating its presence (ESI). The ESI mass spectra of metabolites M1.20 and M1.21 also contained mass ions, m/z 144, corresponding to an unchanged indole ring and m/z 228, further confirming the presence of the carbonyl group on the N-pentylindole moiety. A minor metabolite, M1.22, was found to contain the hydroxyl group on the indole ring.
The fragmentation patterns of the two hydrated metabolites of the compounds 2, M2.20 and M2.21, and their cyclized dehydrated products (M2.20-H 2 O and M2.21-H 2 O) were similar to those of the mono-hydroxylated and di-hydroxylated analogues (Figures 10c and 11) . A metabolite of 2 (without hydration) (M2.22), the analogues of mono-hydroxylated M2.6 and di-hydroxylated M2.12 and M2.13, was also detected (Figure 10d) . The metabolite M2.23 ( Figure 10e ) was tentatively identified as a carboxylated compound.
Metabolites containing a carbonyl group located on the N-pentyl chain have previously been detected as urinary metabolites of JWH-250 and RCS-4 (30, 34) . Additionally, similar compounds were detected as metabolites of JWH-251 and JWH-203 (our unpublished results). Recently, a metabolite with a carbonyl group located on the nonyl side chain was tentatively identified in urine following the ingestion of HU-210 (44) .
N-Dealkylated metabolites with mono-hydroxylation and their hydrated forms
The metabolic profile for the N-dealkylated mono-hydroxylated metabolites is shown in Figures 12-14 . Metabolites M1.30 and M1.31 contain an unchanged indole ring, and the hydroxyl group is located on the tetramethylcyclopropane moiety. The presence of the hydroxyl on the indole moiety in metabolite M1.32 is evidenced by the presence of the ions m/z 125 and 160, in the ESI spectra.
The EI and ESI mass spectra of the hydrated metabolite of compound 2, M2.30 were found to be analogous to those of the N-pentyl analogue. Hydroxylation of the indole ring (M1.32, M2.32 and M2.33) seems less preferable in comparison with hydroxylation of the heptyl moiety (M1.30, M1.31, M2.30 and M2.31). GC-MS detection of the N-dealkylated metabolites was found to be difficult due to strong matrix effects.
Products of acid de-conjugation
The acid de-conjugation of phase I urinary metabolites, with subsequent GC-MS analysis, has proven to be a low-cost and simple method for routine forensic and toxicological analysis (45) . However, in the case of UR-144, the observed metabolic profile is different from that obtained by enzymatic de-conjugation. Using acid de-conjugation, the detection of di-hydroxylated Figure 10 . ESI mass spectra of mono-hydroxylated metabolites with carbonyl group and proposed fragmentation pathways. metabolites M2.10 and M2.11 together with their dehydrated forms ( Figure 8 ) was found to be the most useful method for routine analysis.
Conclusions
Sixteen metabolites of UR-144 and 21 metabolites of the major UR-144 pyrolysis product were detected in urine samples by LC-MS-MS and GC-MS. These were products of hydroxylation, carboxylation and the formation of a carbonyl group on the N-pentyl chain combined with mono-hydroxylation and N-dealkylation with mono-hydroxylation. The metabolism of the UR-144 pyrolysis product (2) resulted in hydration of the aliphatic double bond. Compounds containing hydroxyl groups on the aliphatic moieties were identified as the most abundant metabolites. The detection of mono-hydroxylated metabolites of UR-144 (LC -MS-MS) and mono-hydroxylated/with hydration metabolites of compound 2 (GC-MS) was found to be the most useful method of establishing UR-144 ingestion.
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